Mylan, Sun, Sandoz Get FDA Approval for Generic Casodex

Drug Industry Daily
A A
Sun Pharmaceutical Industries’ and Mylan Pharmaceuticals’ generic versions of the Casodex prostate cancer treatment have received FDA approval.

To View This Article:

Login

Subscribe To Drug Industry Daily